143 related articles for article (PubMed ID: 37182749)
1. Focusing on the 5F-MDMB-PICA, 4F-MDMB-BICA synthetic cannabinoids and their primary metabolites in analytical and pharmacological aspects.
Dvorácskó S; Körmöczi T; Sija É; Bende B; Weiczner R; Varga T; Ilisz I; Institóris L; Kereszty ÉM; Tömböly C; Berkecz R
Toxicol Appl Pharmacol; 2023 Jul; 470():116548. PubMed ID: 37182749
[TBL] [Abstract][Full Text] [Related]
2. Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA-parent compounds and metabolite identification in blood, urine and cerebrospinal fluid.
Tokarczyk B; Jurczyk A; Krupińska J; Adamowicz P
Forensic Sci Med Pathol; 2022 Dec; 18(4):393-402. PubMed ID: 35699867
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and
Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
[TBL] [Abstract][Full Text] [Related]
4. Analytical Methodologies for the Characterization and Analysis of the Parent Compound and Phase I Metabolites of 4F-MDMB-BICA in Human Microsome, Urine, and Blood Samples.
Körmöczi T; Sija É; Institóris L; Kereszty ÉM; Ilisz I; Berkecz R
J Anal Toxicol; 2021 Jan; 46(2):135-45. PubMed ID: 33404059
[TBL] [Abstract][Full Text] [Related]
5. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
[TBL] [Abstract][Full Text] [Related]
6. Methyl (S)-2-(1-7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography-tandem mass spectrometry).
Szpot P; Nowak K; Wachełko O; Tusiewicz K; Chłopaś-Konowałek A; Zawadzki M
Forensic Toxicol; 2023 Jan; 41(1):47-58. PubMed ID: 36652054
[TBL] [Abstract][Full Text] [Related]
7. Study on the metabolic process of synthetic cannabinoids 4F-MDMB-BINACA and 4F-MDMB-BICA in human liver microsome and zebrafish model via UHPLC-QE Orbitrap MS.
Li H; Qian Z; Zhao Y; Zheng H
Anal Bioanal Chem; 2022 May; 414(13):3905-3916. PubMed ID: 35389093
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of the synthetic cannabinoid, 5F-MDMB-PICA, in male rats.
Krotulski AJ; Garibay N; Walther D; Walton SE; Mohr ALA; Logan BK; Baumann MH
Neuropharmacology; 2021 Nov; 199():108800. PubMed ID: 34547333
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
[TBL] [Abstract][Full Text] [Related]
10. The synthetic cannabinoid 5F-MDMB-PICA: A case series.
Kleis J; Germerott T; Halter S; Héroux V; Roehrich J; Schwarz CS; Hess C
Forensic Sci Int; 2020 Sep; 314():110410. PubMed ID: 32683270
[TBL] [Abstract][Full Text] [Related]
11. Sensitive screening of synthetic cannabinoids using liquid chromatography quadrupole time-of-flight mass spectrometry after solid phase extraction.
Kleis JN; Hess C; Germerott T; Roehrich J
Drug Test Anal; 2021 Aug; 13(8):1535-1551. PubMed ID: 33884774
[TBL] [Abstract][Full Text] [Related]
12. [Determination of four amide synthetic cannabinoid isomers by ultra-high performance liquid chromatography-high resolution mass spectrometry].
Tang R; Wang J; Xiao T; Qin S; Jie Z; Zhang A
Se Pu; 2024 Jan; 42(1):84-91. PubMed ID: 38197209
[TBL] [Abstract][Full Text] [Related]
13. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Profiles of 5F-MDMB-PICA in Human Urine, Serum and Hair Samples Using LC-Q Exactive HF-MS.
Qin S; Xin G; Wei J; He G; Yuan Z; Liu H; Zhang X; Wang Y; Zhang W; Lu J
J Anal Toxicol; 2022 Apr; 46(4):408-420. PubMed ID: 33860792
[TBL] [Abstract][Full Text] [Related]
15. Linking in vitro and ex vivo CB
Janssens LK; Hudson S; Wood DM; Wolfe C; Dargan PI; Stove CP
Arch Toxicol; 2022 Nov; 96(11):2935-2945. PubMed ID: 35962200
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing intake and rationalizing toxicities associated with 5F-MDMB-PINACA and 4F-MDMB-BINACA abuse.
Lie W; Cheong EJY; Goh EML; Moy HY; Cannaert A; Stove CP; Chan ECY
Arch Toxicol; 2021 Feb; 95(2):489-508. PubMed ID: 33236189
[TBL] [Abstract][Full Text] [Related]
17. GC-MS/MS analysis of synthetic cannabinoids 5F-MDMB-PICA and 5F-CUMYL-PICA in forensic cases.
Ahmed H; Mujeebuddin S
Bioanalysis; 2024; 16(9):401-413. PubMed ID: 38466892
[TBL] [Abstract][Full Text] [Related]
18. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists.
Marusich JA; Gamage TF; Zhang Y; Akinfiresoye LR; Wiley JL
Pharmacol Biochem Behav; 2022 Oct; 220():173467. PubMed ID: 36154844
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice.
Glatfelter GC; Partilla JS; Baumann MH
Neuropsychopharmacology; 2022 Mar; 47(4):924-932. PubMed ID: 34802041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
